These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16990845)

  • 1. Replication-deficient rSV40 mediate pancreatic gene transfer and long-term inhibition of tumor growth.
    Cordelier P; Bienvenu C; Lulka H; Marrache F; Bouisson M; Openheim A; Strayer DS; Vaysse N; Pradayrol L; Buscail L
    Cancer Gene Ther; 2007 Jan; 14(1):19-29. PubMed ID: 16990845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters.
    Jayan GC; Cordelier P; Patel C; BouHamdan M; Johnson RP; Lisziewicz J; Pomerantz RJ; Strayer DS
    Gene Ther; 2001 Jul; 8(13):1033-42. PubMed ID: 11438838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy using SV40-derived vectors: what does the future hold?
    Strayer DS
    J Cell Physiol; 1999 Dec; 181(3):375-84. PubMed ID: 10528223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both HIV- and EIAV-based lentiviral vectors mediate gene delivery to pancreatic cancer cells and human pancreatic primary patient xenografts.
    Saraga G; Mafficini A; Ghaneh P; Sorio C; Costello E
    Cancer Gene Ther; 2007 Sep; 14(9):781-90. PubMed ID: 17571071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SV40-based gene therapy vectors: turning an adversary into a friend.
    Strayer DS
    Curr Opin Mol Ther; 2000 Oct; 2(5):570-8. PubMed ID: 11249759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What can SV40-derived vectors do for gene therapy?
    Strayer DS; Zern MA; Chowdhury JR
    Curr Opin Mol Ther; 2002 Aug; 4(4):313-23. PubMed ID: 12222869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of SV40-based vectors to transduce foreign genes to normal human peripheral blood mononuclear cells.
    Strayer DS; Kondo R; Milano J; Duan LX
    Gene Ther; 1997 Mar; 4(3):219-25. PubMed ID: 9135735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of recombinant adenovirus vector mediated human interleukin-24 gene transfection on pancreatic carcinoma growth.
    Pan XT; Zhu QY; Li DC; Yang JC; Zhang ZX; Zhu XG; Zhao H
    Chin Med J (Engl); 2008 Oct; 121(20):2031-6. PubMed ID: 19080270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the bystander effect of somatostatin receptor sst2 after in vivo gene transfer into human pancreatic cancer cells.
    Carrere N; Vernejoul F; Souque A; Asnacios A; Vaysse N; Pradayrol L; Susini C; Buscail L; Cordelier P
    Hum Gene Ther; 2005 Oct; 16(10):1175-93. PubMed ID: 16218779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulated hsp70B' promoter: stringent heat-inducible activity in replication-deficient, but not replication-competent adenoviruses.
    Rohmer S; Mainka A; Knippertz I; Hesse A; Nettelbeck DM
    J Gene Med; 2008 Apr; 10(4):340-54. PubMed ID: 18265421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Titering replication-defective rSV40 vectors.
    Strayer DS; Mitchell C; Maier DA; Nichols CN
    Cold Spring Harb Protoc; 2010 Jun; 2010(6):pdb.prot5437. PubMed ID: 20516175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
    Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
    Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of recombinant SV40 vectors for gene transfer.
    Strayer DS; Lamothe M; Wei D; Milano J; Kondo R
    Methods Mol Biol; 2001; 165():103-17. PubMed ID: 11217380
    [No Abstract]   [Full Text] [Related]  

  • 14. Gene transfer-mediated pre-mRNA segmental trans-splicing as a strategy to deliver intracellular toxins for cancer therapy.
    Nakayama K; Pergolizzi RG; Crystal RG
    Cancer Res; 2005 Jan; 65(1):254-63. PubMed ID: 15665302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SV40 mediates stable gene transfer in vivo.
    Strayer DS; Milano J
    Gene Ther; 1996 Jul; 3(7):581-7. PubMed ID: 8818644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic gene delivery of interferon-inducible protein 10 through replication-competent retrovirus vectors suppresses tumor growth.
    Sun Y; Finger C; Alvarez-Vallina L; Cichutek K; Buchholz CJ
    Cancer Gene Ther; 2005 Nov; 12(11):900-12. PubMed ID: 15905858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing the production of recombinant SV40 vectors.
    Vera M; Prieto J; Strayer DS; Fortes P
    Mol Ther; 2004 Oct; 10(4):780-91. PubMed ID: 15451462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.
    Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4511-8. PubMed ID: 17671137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells.
    Chen L; Chen D; Gong M; Na M; Li L; Wu H; Jiang L; Qian Y; Fang G; Xue X
    Cancer Lett; 2009 Nov; 284(2):141-8. PubMed ID: 19447545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for CNS-directed gene delivery: in vivo gene transfer to the brain using SV40-derived vectors.
    Louboutin JP; Reyes BA; Agrawal L; Van Bockstaele E; Strayer DS
    Gene Ther; 2007 Jun; 14(12):939-49. PubMed ID: 17443215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.